Sanofi (FRA:SNW)
Germany
· Delayed Price · Currency is EUR 92.70
-0.63 (-0.68%)
At close: Apr 25, 2025, 10:00 PM CET
Sanofi Revenue
Sanofi had revenue of 10.61B EUR in the quarter ending March 31, 2025, a decrease of -4.61%. This brings the company's revenue in the last twelve months to 45.17B, down -2.42% year-over-year. In the year 2024, Sanofi had annual revenue of 44.29B with 7.73% growth.
Revenue (ttm)
45.17B
Revenue Growth
-2.42%
P/S Ratio
2.53
Revenue / Employee
544.97K
Employees
82,878
Market Cap
114.26B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 44.29B | 3.18B | 7.73% |
| Dec 31, 2023 | 41.11B | 805.00M | 2.00% |
| Dec 31, 2022 | 40.30B | 1.13B | 2.88% |
| Dec 31, 2021 | 39.18B | 1.81B | 4.83% |
| Dec 31, 2020 | 37.37B | -262.00M | -0.70% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 35.15B |
| Deutsche Telekom AG | 118.43B |
| Siemens Aktiengesellschaft | 76.54B |
| Allianz SE | 107.35B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 61.15B |
| Rheinmetall AG | 9.75B |
| Merck KGaA | 21.16B |
| Siemens Energy AG | 35.76B |
Sanofi News
- 1 day ago - Sanofi (SNY) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 1 day ago - Sanofi 2025 Q1 - Results - Earnings Call Presentation - Seeking Alpha
- 1 day ago - Sanofi proposes annual dividend of €3.92, a hike of 4.26% from prior dividend - Seeking Alpha
- 1 day ago - Pharma Giant Roche Tops First-Quarter Views; Sanofi's Sales Come In Mixed - Investor's Business Daily
- 1 day ago - EU pharma majors Sanofi, Roche trade flat after reiterated guidance - Seeking Alpha
- 1 day ago - Sanofi Sales, Profit Beat Expectations on Higher Demand for Skin, Asthma Drug - WSJ
- 1 day ago - Sanofi Sales, Profit Beat Expectations on Higher Demand for Skin, Asthma Drug - The Wall Street Journal
- 1 day ago - Sanofi beats top-line and bottom-line estimates; reaffirms FY25 outlook - Seeking Alpha